Evidence map›Paper›PMID 41546507›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2026

Proteomic Profiling of Alveolar Macrophages Identifies Loss of Lysosomal Content as an Indicator of Nanofiber-Induced Frustrated Phagocytosis.

Tobias Stobernack, Antje Vennemann, Carla Ribalta, Julia Schendel, Oliver Gräb, Rico Ledwith, Mario Pink, Andrea Haase, Martin Wiemann, Verónica I Dumit

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tobias StobernackDepartment of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.ORCID https://orcid.org/0000-0002-2839-1555
Antje VennemannIBE R&D Institute for Lung Health gGmbH, Münster, Germany.
Carla RibaltaDepartment of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Julia SchendelDepartment of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Oliver GräbIBE R&D Institute for Lung Health gGmbH, Münster, Germany.
Rico LedwithDepartment of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Mario PinkDepartment of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Andrea HaaseDepartment of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Martin WiemannIBE R&D Institute for Lung Health gGmbH, Münster, Germany.
Verónica I DumitDepartment of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.ORCID https://orcid.org/0009-0002-5091-4284

Funding

Bundesinstitut für Risikobewertung SFP 1322-777Federal Ministry of Education and Research 03XP0216Horizon 2020 Framework Programme 953183
6 · The paper itself

Abstract

Toxicological research on inhalable fibers, such as asbestos, has identified material morphology (i.e., length and diameter) and bio-persistence as drivers of adverse health effects (e.g., fibrosis, lung cancer, mesothelioma). Although nanofibers may meet these criteria, their small diameters may enable them to adopt different shapes, affecting their toxicity. While nanofiber pathogenicity is still assessed using animal models, the development of alternative in vitro methods relies on a mechanistic understanding of toxicity. Here, we address nanofiber-induced protein changes in alveolar macrophages by analyzing whole cell lysates and supernatants of NR8383 cells exposed to silicon carbide nanofibers, Mitsui-7 carbon nanotubes, and Printex-90. While all materials elicited a similar dose-dependent cytotoxicity, there was a nanofiber-specific release of TNF-α and glucuronidase. Proteomic profiling after treatment with low, non-cytotoxic concentrations confirmed the inflammatory response and revealed a release of 20 lysosomal, luminal hydrolases, including six cathepsins, into the extracellular supernatant. In cell lysates, these hydrolases were decreased, while membrane-associated lysosomal proteins remained unchanged, suggesting that macrophages engulfing long nanofibers release lysosomal content from open membrane pouches during frustrated phagocytosis. Additionally, 17 biomarkers of nanofiber-induced toxicity were identified as potential targets for predictive, animal-free screening. These early markers may be of value for assessing nanofiber toxicity.

Indexed as

LysosomesMacrophages, AlveolarNanofibersPhagocytosisProteomicsAnimalsCell LineNanotubes, CarbonRatsTumor Necrosis Factor-alphaNanotubes, CarbonTumor Necrosis Factor-alphafiber pathogenicity paradigm (FPP)Mitsui‐7NR8383silicon carbidetoxicity

Identifiers

PMID41546507
PMCPMC12921543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.